189 related articles for article (PubMed ID: 34375725)
1. Multifunctional plant virus nanoparticles in the next generation of cancer immunotherapies.
Shahgolzari M; Dianat-Moghadam H; Fiering S
Semin Cancer Biol; 2022 Nov; 86(Pt 2):1076-1085. PubMed ID: 34375725
[TBL] [Abstract][Full Text] [Related]
2. Emerging Potential of Plant Virus Nanoparticles (PVNPs) in Anticancer Immunotherapies.
Shahgolzari M; Fiering S
J Cancer Immunol (Wilmington); 2022; 4(1):22-29. PubMed ID: 35600219
[TBL] [Abstract][Full Text] [Related]
3. Plant Virus Nanoparticles for Vaccine Applications.
Santoni M; Zampieri R; Avesani L
Curr Protein Pept Sci; 2020; 21(4):344-356. PubMed ID: 32048964
[TBL] [Abstract][Full Text] [Related]
4. Potentiating Cancer Immunotherapy Using Papaya Mosaic Virus-Derived Nanoparticles.
Lebel MÈ; Chartrand K; Tarrab E; Savard P; Leclerc D; Lamarre A
Nano Lett; 2016 Mar; 16(3):1826-32. PubMed ID: 26891174
[TBL] [Abstract][Full Text] [Related]
5. Gold nanoparticle mediated cancer immunotherapy.
Almeida JP; Figueroa ER; Drezek RA
Nanomedicine; 2014 Apr; 10(3):503-14. PubMed ID: 24103304
[TBL] [Abstract][Full Text] [Related]
6. Plant Viral Nanoparticle Conjugated with Anti-PD-1 Peptide for Ovarian Cancer Immunotherapy.
Gautam A; Beiss V; Wang C; Wang L; Steinmetz NF
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575893
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous Silica as a Versatile Platform for Cancer Immunotherapy.
Nguyen TL; Choi Y; Kim J
Adv Mater; 2019 Aug; 31(34):e1803953. PubMed ID: 30417454
[TBL] [Abstract][Full Text] [Related]
8. Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigen.
Hashemi Goradel N; Nemati M; Bakhshandeh A; Arashkia A; Negahdari B
Int Immunopharmacol; 2023 Apr; 117():109887. PubMed ID: 36841155
[TBL] [Abstract][Full Text] [Related]
9. Recombinant helical plant virus-based nanoparticles for vaccination and immunotherapy.
Narayanan KB; Han SS
Virus Genes; 2018 Oct; 54(5):623-637. PubMed ID: 30008053
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines.
Da Silva CG; Camps MGM; Li TMWY; Chan AB; Ossendorp F; Cruz LJ
Biomaterials; 2019 Nov; 220():119417. PubMed ID: 31419588
[TBL] [Abstract][Full Text] [Related]
11. Plant Virus Nanoparticles Combat Cancer.
Shahgolzari M; Venkataraman S; Osano A; Akpa PA; Hefferon K
Vaccines (Basel); 2023 Jul; 11(8):. PubMed ID: 37631846
[TBL] [Abstract][Full Text] [Related]
12. The quest for nanoparticle-powered vaccines in cancer immunotherapy.
Sun Z; Zhao H; Ma L; Shi Y; Ji M; Sun X; Ma D; Zhou W; Huang T; Zhang D
J Nanobiotechnology; 2024 Feb; 22(1):61. PubMed ID: 38355548
[TBL] [Abstract][Full Text] [Related]
13. RNA Nanotechnology-Mediated Cancer Immunotherapy.
Lin YX; Wang Y; Blake S; Yu M; Mei L; Wang H; Shi J
Theranostics; 2020; 10(1):281-299. PubMed ID: 31903120
[TBL] [Abstract][Full Text] [Related]
14. Combination of Plant Virus Nanoparticle-Based in Situ Vaccination with Chemotherapy Potentiates Antitumor Response.
Lee KL; Murray AA; Le DHT; Sheen MR; Shukla S; Commandeur U; Fiering S; Steinmetz NF
Nano Lett; 2017 Jul; 17(7):4019-4028. PubMed ID: 28650644
[TBL] [Abstract][Full Text] [Related]
15. Combinatory therapy adopting nanoparticle-based cancer vaccination with immune checkpoint blockade for treatment of post-surgical tumor recurrences.
Chung CK; Da Silva CG; Kralisch D; Chan A; Ossendorp F; Cruz LJ
J Control Release; 2018 Sep; 285():56-66. PubMed ID: 30008371
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Vaccines for Cancer Immunotherapy.
Wang J; Mamuti M; Wang H
ACS Biomater Sci Eng; 2020 Nov; 6(11):6036-6052. PubMed ID: 33449675
[TBL] [Abstract][Full Text] [Related]
17. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional nanoparticles for cancer immunotherapy.
Saleh T; Shojaosadati SA
Hum Vaccin Immunother; 2016 Jul; 12(7):1863-75. PubMed ID: 26901287
[TBL] [Abstract][Full Text] [Related]
19. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.
Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J
J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642
[TBL] [Abstract][Full Text] [Related]
20. The application of nanotechnology in enhancing immunotherapy for cancer treatment: current effects and perspective.
Li Y; Ayala-Orozco C; Rauta PR; Krishnan S
Nanoscale; 2019 Oct; 11(37):17157-17178. PubMed ID: 31531445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
